Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Philip Reigan and Becka Warfield.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.103 |
|
|
|
-
Warfield BM, Reigan P. Multifunctional role of thymidine phosphorylase in cancer. Trends Cancer. 2022 Jun; 8(6):482-493.
Score: 0.977
-
Warfield BM, Casalvieri KA, Matheson CJ, Backos DS, Reigan P. Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling data. Data Brief. 2021 Oct; 38:107433.
Score: 0.950
-
Warfield BM, Matheson CJ, McArthur DG, Backos DS, Reigan P. Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation. ACS Chem Neurosci. 2021 09 15; 12(18):3477-3486.
Score: 0.946
-
Casalvieri KA, Matheson CJ, Warfield BM, Backos DS, Reigan P. N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors. Bioorg Med Chem. 2021 07 01; 41:116220.
Score: 0.232